Robotic right hepatectomy for giant hepatocellular adenoma – With video

Abstract A 56-year-old man presented with an 11-cm hepatocellular carcinoma (HCC) at segment 7 of liver. To induce left liver hypertrophy, a sequential transarterial chemoembolization (TACE) and portal vein embolization before right hepatectomy were adopted. However, the tumor further increased in size despite TACE and invaded through the diaphragm to the right lung base. Anterior approach right hepatectomy with en bloc wedge resection of the involved right lower lobe of lung by endovascular staplers via transdiaphragmatic approach was performed. The diaphragmatic defect was closed with Goretex mesh. Patient made an uneventful recovery. Pathology confirmed a 12.5 cm poorly differentiated HCC invading through diaphragm to lung. During follow-up, patient developed a 6 cm recurrence at left lung base 17 months after surgery for which he received sorafenib therapy. However, the lung mass further increased in size with new liver recurrence at segment 3 despite treatment. He succumbed 2 years and 3 months after surgery.

Download Full-text

Hepatocellular adenoma, approximately half and predominantly inflammatory subtype, in 38 Japanese patients with several differences in age, gender and clinical background factors from Western populations

Hepatology Research ◽

10.1111/hepr.13613 ◽

2020 ◽

Author(s):

Asami Izu ◽

Masahiko Sugitani ◽

Noriko Kinukawa ◽

Hiroshi Matsumura ◽

Masahiro Ogawa ◽

...

Keyword(s):

Hepatocellular Adenoma ◽

Japanese Patients ◽

Background Factors ◽

Clinical Background

Download Full-text

Right hepatectomy as a salvage treatment for stewart-way type IV bile duct injury

HPB ◽

10.1016/j.hpb.2020.04.718 ◽

2020 ◽

Vol 22 ◽

pp. S170

Author(s):

J.L. Beristain-Hernandez ◽

M. Garcia-Sanchez

Keyword(s):

Bile Duct ◽

Bile Duct Injury ◽

Salvage Treatment ◽

Right Hepatectomy ◽

Type Iv

Download Full-text

Video presentation: Robotic right hepatectomy for metastatic colorectal cancer

HPB ◽

10.1016/j.hpb.2020.04.638 ◽

2020 ◽

Vol 22 ◽

pp. S128-S129

Author(s):

R.S. Meltzer ◽

B.I. Meyer ◽

M.M. Shah ◽

D.A. Kooby

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Right Hepatectomy ◽

Video Presentation

Download Full-text

Oncological Outcomes after Liver Venous Deprivation for Colorectal Liver Metastases: A Single Center Experience

Cancers ◽

10.3390/cancers13020200 ◽

2021 ◽

Vol 13 (2) ◽

pp. 200

Author(s):

Salah Khayat ◽

Gianluca Cassese ◽

François Quenet ◽

Christophe Cassinotto ◽

Eric Assenat ◽

...

Keyword(s):

Portal Vein ◽

Liver Metastases ◽

Portal Vein Embolization ◽

Colorectal Liver Metastases ◽

Future Liver Remnant ◽

Small Sample ◽

Right Hepatectomy ◽

Liver Remnant ◽

Oncological Outcomes ◽

Extended Right Hepatectomy

Colorectal liver metastases (CRLM) are the major cause of death in patients with colorectal cancer (CRC). The cornerstone treatment of CRLM is surgical resection. Post-operative morbidity and mortality are mainly linked to an inadequate future liver remnant (FLR). Nowadays preoperative portal vein embolization (PVE) is the most widely performed technique to increase the size of the future liver remnant (FLR) before major hepatectomies. One method recently proposed to increase the FLR is liver venous deprivation (LVD), but its oncological impact is still unknown. The aim of this study is to report first short- and long-term oncological outcomes after LVD in patients undergoing right (or extended right) hepatectomy for CRLM. Seventeen consecutive patients undergoing LVD between July 2015 and May 2020 before an (extended) right hepatectomy were retrospectively analyzed from an institutional database. Post-operative and follow-up data were analyzed and reported. Primary outcomes were 1-year and 3-year overall survival (OS) and hepatic recurrence (HR). Postoperative complications occurred in 8 patients (47%). No deaths occurred after surgery. HR occurred in 9 patients (52.9%). 1-year and 3-year OS were 87% (95% confidence interval [CI]: ±16%) and 60.3%, respectively (95% CI: ±23%). Median Disease-Free Survival (DFS) was 6 months (CI 95%: 4.7–7.2). With all the limitations of a retrospective study with a small sample size, LVD showed similar oncological outcomes compared to literature reports for Portal Vein Embolization (PVE).

Download Full-text

Intrahepatic Glissonian approach for robotic right hepatectomy

Surgical Oncology ◽

10.1016/j.suronc.2021.101579 ◽

2021 ◽

pp. 101579

Author(s):

Marcel Autran Machado ◽

Bruno H. Mattos ◽

Murillo Lobo Filho ◽

Fábio Makdissi

Keyword(s):

Right Hepatectomy ◽

Glissonian Approach

Download Full-text

Primary renal synovial sarcoma presenting with a retroperitoneal bleed

BMJ Case Reports ◽

10.1136/bcr-2020-237099 ◽

2021 ◽

Vol 14 (3) ◽

pp. e237099

Author(s):

Daanesh Huned ◽

Juinn Huar Kam ◽

Lui Shiong Lee ◽

Raj Vikesh Tiwari

Keyword(s):

Differential Diagnosis ◽

Case Report ◽

Synovial Sarcoma ◽

Soft Tissue Mass ◽

Renal Angiomyolipoma ◽

Right Hepatectomy ◽

Tissue Mass ◽

Biopsy Confirmation ◽

Synovial Sarcomas ◽

Neo Adjuvant Chemotherapy

Synovial sarcomas are most commonly localised in extremities, especially in the lower thigh and knee areas. Comprising less than 1% of all malignancies, retroperitoneal synovial sarcoma is very rare with primary synovial sarcoma of the kidney being even more infrequent and difficult to diagnose. We describe a case report of a renal synovial sarcoma in a young adult who was initially managed as a case of Wunderlich’s syndrome secondary to what was believed to be a ruptured renal angiomyolipoma. After biopsy confirmation, the patient was eventually managed with neo-adjuvant chemotherapy followed by a right radical nephrectomy and right hepatectomy. Despite its rarity, synovial sarcoma should be considered as differential diagnosis of a bleeding retroperitoneal soft tissue mass detected in young adults.

Download Full-text